The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection
Open accessAbstract
Summary Infection with the opportunistic enteric pathogen Clostridium difficile is an increasingly common clinical complication that follows antibiotic treatment-induced gut microbiota perturbation. Innate lymphoid cells (ILCs) are early responders to enteric pathogens; however, their role during C. difficile infection is undefined. To identify immune pathways that mediate recovery from C. difficile infection, we challenged C57BL/6, Rag1−/−, which lack T and B cells, and Rag2−/− Il2rg−/− (Ragγc−/−) mice, which additionally lack ILCs, with C. difficile. In contrast to Rag1−/− mice, ILC-deficient Ragγc−/− mice rapidly succumbed to infection. Rag1−/−, but not Ragγc−/− mice, upregulate expression of ILC1 or ILC3 associated proteins following C. difficile infection. Protection against infection was restored by transferring ILCs into Ragγc−/− mice. While ILC3s made a minor contribution to resistance, loss of IFN-γ or T-bet-expressing ILC1s in Rag1−/− mice increased susceptibility to C. difficile. These data demonstrate a critical role for ILC1s in defense against C. difficile.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
Zheng, Y., Valdez, P. A., Danilenko, D. M., Hu, Y., Sa, S. M., Gong, Q., Abbas, A. R., Modrusan, Z., Ghilardi, N., de Sauvage, F. J., et al. (2008) · Nature Medicine · doi:10.1038/nm1720 · Cited by 1,921
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
Buffie, C. G., Bucci, V., Stein, R. R., McKenney, P. T., Ling, L., Gobourne, A., No, D., Liu, H., Kinnebrew, M., Viale, A., et al. (2015) · Nature · doi:10.1038/nature13828 · Cited by 1,872
Self-citationThe biology of innate lymphoid cells
Artis, D., & Spits, H. (2015) · Nature · doi:10.1038/nature14189 · Cited by 1,634
Ye, P., Rodriguez, F. H., Kanaly, S., Stocking, K. L., Schurr, J., Schwarzenberger, P., Oliver, P., Huang, W., Zhang, P., Zhang, J., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.519 · Cited by 1,521
Clostridium difficile infection: new developments in epidemiology and pathogenesis
Rupnik, M., Wilcox, M. H., & Gerding, D. N. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2164 · Cited by 1,380 · cited 4×
“C. difficile establishes infection following disruption of the indigenous microbiota, usually the result of preceding antibiotic treatment (Rupnik et al., 2009; Viswanathan et al., 2010).”
BackgroundMethodInfluentialClostridium difficile Toxins: Mechanism of Action and Role in Disease
Voth, D. E., & Ballard, J. D. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.247-263.2005 · Cited by 1,104
Satoh-Takayama, N., Vosshenrich, C. A. J., Lesjean-Pottier, S., Sawa, S., Lochner, M., Rattis, F., Mention, J.-J., Thiam, K., Cerf-Bensussan, N., Mandelboim, O., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.11.001 · Cited by 1,095
Klose, C. S. N., Flach, M., Möhle, L., Rogell, L., Hoyler, T., Ebert, K., Fabiunke, C., Pfeifer, D., Sexl, V., Fonseca-Pereira, D., et al. (2014) · Cell · doi:10.1016/j.cell.2014.03.030 · Cited by 1,080
Glucosylation of Rho proteins by Clostridium difficile toxin B
Just, I., Selzer, J., Wilm, M., Eichel-Streiber, C. V., Mann, M., & Aktories, K. (1995) · Nature · doi:10.1038/375500a0 · Cited by 1,032
Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues
Bernink, J. H., Peters, C. P., Munneke, M., te Velde, A. A., Meijer, S. L., Weijer, K., Hreggvidsdottir, H. S., Heinsbroek, S. E., Legrand, N., Buskens, C. J., et al. (2013) · Nature Immunology · doi:10.1038/ni.2534 · Cited by 1,006
Eberl, G., Marmon, S., Sunshine, M.-J., Rennert, P. D., Choi, Y., & Littman, D. R. (2004) · Nature Immunology · doi:10.1038/ni1022 · Cited by 985
Asymptomatic Carriage of Clostridium difficile and Serum Levels of IgG Antibody against Toxin A
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420604 · Cited by 935
Communicable Ulcerative Colitis Induced by T-bet Deficiency in the Innate Immune System
Garrett, W. S., Lord, G. M., Punit, S., Lugo-Villarino, G., Mazmanian, S. K., Ito, S., Glickman, J. N., & Glimcher, L. H. (2007) · Cell · doi:10.1016/j.cell.2007.08.017 · Cited by 918
Fuchs, A., Vermi, W., Lee, J. S., Lonardi, S., Gilfillan, S., Newberry, R. D., Cella, M., & Colonna, M. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.010 · Cited by 907
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03592-3 · Cited by 804
Toxin B is essential for virulence of Clostridium difficile
Lyras, D., O’Connor, J. R., Howarth, P. M., Sambol, S. P., Carter, G. P., Phumoonna, T., Poon, R., Adams, V., Vedantam, G., Johnson, S., et al. (2009) · Nature · doi:10.1038/nature07822 · Cited by 745
The Transcription Factors T-bet and Eomes Control Key Checkpoints of Natural Killer Cell Maturation
Gordon, S. M., Chaix, J., Rupp, L. J., Wu, J., Madera, S., Sun, J. C., Lindsten, T., & Reiner, S. L. (2012) · Immunity · doi:10.1016/j.immuni.2011.11.016 · Cited by 731
A T-bet gradient controls the fate and function of CCR6−RORγt+ innate lymphoid cells
Klose, C. S. N., Kiss, E. A., Schwierzeck, V., Ebert, K., Hoyler, T., d’Hargues, Y., Göppert, N., Croxford, A. L., Waisman, A., Tanriver, Y., et al. (2013) · Nature · doi:10.1038/nature11813 · Cited by 719
Stress, Inflammation, and Defense of Homeostasis
Chovatiya, R., & Medzhitov, R. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.030 · Cited by 704
Buffie, C. G., Jarchum, I., Equinda, M., Lipuma, L., Gobourne, A., Viale, A., Ubeda, C., Xavier, J., & Pamer, E. G. (2012) · Infection and Immunity · doi:10.1128/iai.05496-11 · Cited by 596 · cited 5×
“Mice were then treated with neomycin (0.25 g/l) and vancomycin (0.25 g/l) in the drinking water for 3 days, followed by a single intraperitoneal (i.p.) injection of clindamycin (Buffie et al., 2012; Lewis et al., 2015; Rupnik et al., 2009; Wren et al., 2005) (Figure S1A).”
BackgroundMethodInfluentialSelf-citationCD4+ Lymphoid Tissue-Inducer Cells Promote Innate Immunity in the Gut
Sonnenberg, G. F., Monticelli, L. A., Elloso, M. M., Fouser, L. A., & Artis, D. (2011) · Immunity · doi:10.1016/j.immuni.2010.12.009 · Cited by 572
Increasing Risk of Relapse after Treatment of Clostridium difficile Colitis in Quebec, Canada
Pepin, J., Alary, M.-E., Valiquette, L., Raiche, E., Ruel, J., Fulop, K., Godin, D., & Bourassa, C. (2005) · Clinical Infectious Diseases · doi:10.1086/430315 · Cited by 570
Lawley, T. D., Clare, S., Walker, A. W., Stares, M. D., Connor, T. R., Raisen, C., Goulding, D., Rad, R., Schreiber, F., Brandt, C., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002995 · Cited by 540
Thymic Origin of Intestinal αß T Cells Revealed by Fate Mapping of RORγt + Cells
Eberl, G., & Littman, D. R. (2004) · Science · doi:10.1126/science.1096472 · Cited by 513
A mouse model of clostridium difficile-associated disease
Chen, X., Katchar, K., Goldsmith, J. D., Nanthakumar, N., Cheknis, A., Gerding, D. N., & Kelly, C. P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.09.002 · Cited by 510
Kinnebrew, M. A., Buffie, C. G., Diehl, G. E., Zenewicz, L. A., Leiner, I., Hohl, T. M., Flavell, R. A., Littman, D. R., & Pamer, E. G. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.011 · Cited by 491
Self-citationCitrobacter rodentium of mice and man
Mundy, R., MacDonald, T. T., Dougan, G., Frankel, G., & Wiles, S. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00625.x · Cited by 481
Recurrent Clostridium difficile infection: A review of risk factors, treatments, and outcomes
Johnson, S. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.03.010 · Cited by 397
Gladiator, A., Wangler, N., Trautwein-Weidner, K., & LeibundGut-Landmann, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202924 · Cited by 382
Lawley, T. D., Clare, S., Walker, A. W., Goulding, D., Stabler, R. A., Croucher, N., Mastroeni, P., Scott, P., Raisen, C., Mottram, L., et al. (2009) · Infection and Immunity · doi:10.1128/iai.00558-09 · Cited by 349
Recovery of the Gut Microbiome following Fecal Microbiota Transplantation
Seekatz, A. M., Aas, J., Gessert, C. E., Rubin, T. A., Saman, D. M., Bakken, J. S., & Young, V. B. (2014) · mBio · doi:10.1128/mbio.00893-14 · Cited by 331
Powell, N., Walker, A. W., Stolarczyk, E., Canavan, J. B., Gökmen, M. R., Marks, E., Jackson, I., Hashim, A., Curtis, M. A., Jenner, R. G., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.09.008 · Cited by 324
Ubeda, C., Lipuma, L., Gobourne, A., Viale, A., Leiner, I., Equinda, M., Khanin, R., & Pamer, E. G. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120504 · Cited by 310
Self-citationGeiger, T. L., Abt, M. C., Gasteiger, G., Firth, M. A., O’Connor, M. H., Geary, C. D., O’Sullivan, T. E., van den Brink, M. R., Pamer, E. G., Hanash, A. M., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140212 · Cited by 269
Self-citationLewis, B. B., Buffie, C. G., Carter, R. A., Leiner, I., Toussaint, N. C., Miller, L. C., Gobourne, A., Ling, L., & Pamer, E. G. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv256 · Cited by 197
Hasegawa, M., Yamazaki, T., Kamada, N., Tawaratsumida, K., Kim, Y.-G., Núñez, G., & Inohara, N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003761 · Cited by 186
Hasegawa, M., Yada, S., Liu, M. Z., Kamada, N., Muñoz-Planillo, R., Do, N., Núñez, G., & Inohara, N. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.010 · Cited by 170
Antimicrobial resistance in Clostridium difficile
Huang, H., Weintraub, A., Fang, H., & Nord, C. E. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.09.012 · Cited by 169
Toll-Like Receptor 5 Stimulation Protects Mice from Acute Clostridium difficile Colitis
Jarchum, I., Liu, M., Lipuma, L., & Pamer, E. G. (2011) · Infection and Immunity · doi:10.1128/iai.01196-10 · Cited by 154
Self-citationCritical Role for MyD88-Mediated Neutrophil Recruitment during Clostridium difficile Colitis
Jarchum, I., Liu, M., Shi, C., Equinda, M. J., & Pamer, E. G. (2012) · Infection and Immunity · doi:10.1128/iai.00448-12 · Cited by 154
Self-citationBoyman, O., Ramsey, C., Kim, D. M., Sprent, J., & Surh, C. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7265 · Cited by 151
Wren, S. M. (2005) · Archives of Surgery · doi:10.1001/archsurg.140.8.752 · Cited by 142
Hasegawa, M., Kamada, N., Jiao, Y., Liu, M. Z., Núñez, G., & Inohara, N. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200821 · Cited by 140
CD160 is essential for NK-mediated IFN-γ production
Tu, T., Brown, N. K., Kim, T.-J., Wroblewska, J., Yang, X., Guo, X., Lee, S. H., Kumar, V., Lee, K., & Fu, Y. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20131601 · Cited by 134
Viswanathan, V. K., Mallozzi, M., & Vedantam, G. (2010) · Gut Microbes · doi:10.4161/gmic.1.4.12706 · Cited by 115
Variations in Virulence and Molecular Biology among Emerging Strains of Clostridium difficile
Hunt, J. J., & Ballard, J. D. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00017-13 · Cited by 112
Clostridium difficileinfection in cancer patients and hematopoietic stem cell transplant recipients
Chopra, T., Alangaden, G. J., & Chandrasekar, P. H. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.95 · Cited by 83
Role of Interleukin 23 Signaling in Clostridium difficile Colitis
Buonomo, E. L., Madan, R., Pramoonjago, P., Li, L., Okusa, M. D., & Petri, W. A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit277 · Cited by 83
Human monocytes produce interferon-gamma upon stimulation with LPS
Kraaij, M. D., Vereyken, E. J. F., Leenen, P. J. M., van den Bosch, T. P. P., Rezaee, F., Betjes, M. G. H., Baan, C. C., & Rowshani, A. T. (2014) · Cytokine · doi:10.1016/j.cyto.2014.02.001 · Cited by 77
Dubberke, E. R., Reske, K. A., Srivastava, A., Sadhu, J. S., Gatti, R., Young, R. M., Rakes, L. C., Dieckgraefe, B. K., DiPersio, J. F., & Fraser, V. J. (2009) · Clinical Transplantation · doi:10.1111/j.1399-0012.2009.01035.x · Cited by 75
SnapShot: Innate Lymphoid Cells
Sonnenberg, G. F., Mjösberg, J., Spits, H., & Artis, D. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.021 · Cited by 64
Warren, C. A., van Opstal, E. J., Ballard, T. E., Kennedy, A., Xia, W., Riggins, M. S., Olekhnovich, I. N., Warthan, M., Kolling, G. L., Guerrant, R. L., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00360-12 · Cited by 64
Tvede, M., Tinggaard, M., & Helms, M. (2014) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.07.003 · Cited by 51
Spees, A. M., Kingsbury, D. D., Wangdi, T., Byndloss, M. X., Tsolis, R. M., & Bäumler, A. J. (2014) · Infection and Immunity · doi:10.1128/iai.01508-13 · Cited by 47
Innate lymphoid cells in the defense against infections
Diefenbach, A. (2013) · European Journal of Microbiology and Immunology · doi:10.1556/eujmi.3.2013.3.1 · Cited by 42
Akha, A. A. S., Theriot, C. M., Erb‐Downward, J. R., McDermott, A. J., Falkowski, N. R., Tyra, H. M., Rutkowski, D. T., Young, V. B., & Huffnagle, G. B. (2013) · Immunology · doi:10.1111/imm.12122 · Cited by 42
Akha, A. A. S., McDermott, A. J., Theriot, C. M., Carlson, P. E., Frank, C. R., McDonald, R. A., Falkowski, N. R., Bergin, I. L., Young, V. B., & Huffnagle, G. B. (2014) · Immunology · doi:10.1111/imm.12414 · Cited by 26
McDermott, A. J., Higdon, K. E., Muraglia, R., Erb‐Downward, J. R., Falkowski, N. R., McDonald, R. A., Young, V. B., & Huffnagle, G. B. (2014) · Immunology · doi:10.1111/imm.12425 · Cited by 25
Cited by
Innate Lymphoid Cells: 10 Years On
Vivier, E., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J. P., Eberl, G., Koyasu, S., Locksley, R. M., McKenzie, A. N. J., Mebius, R. E., et al. (2018) · Cell · doi:10.1016/j.cell.2018.07.017 · Cited by 2,124
Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease
Pickard, J. M., Zeng, M. Y., Caruso, R., & Núñez, G. (2017) · Immunological Reviews · doi:10.1111/imr.12567 · Cited by 1,699
Clostridium difficile infection
Smits, W. K., Lyras, D., Lacy, D. B., Wilcox, M. H., & Kuijper, E. J. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.20 · Cited by 853
The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens
Kim, S., Covington, A., & Pamer, E. G. (2017) · Immunological Reviews · doi:10.1111/imr.12563 · Cited by 741
Self-citationClostridium difficile colitis: pathogenesis and host defence
Abt, M. C., McKenney, P. T., & Pamer, E. G. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.108 · Cited by 551
Self-citation
Metadata
- Authors
- Abt, M. C., Lewis, B. B., Caballero, S., Xiong, H., Carter, R. A., Sušac, B., Ling, L., Leiner, I., & Pamer, E. G.
- Venue
- Cell Host & Microbe
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 18
- Issue
- 1
- Pages
- 27-37
- ISSN
- 1931-3128 (ISSN-L)
- OpenAlex
- W1913844335
- Cited by
- 294
- References
- 58
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.